EGFR mutations are found in approximately 60% of never-smoking Asian patients with adenocarcinomas compared to 5–10% in Caucasians, and thus represent a significant proportion of NSCLC in our local context (9, 10). This evidence concerns the gene EGFR and non-small cell lung carcinoma.